2025 India Allergy Immunotherapy Revenue Opportunities Report
Description
The 2025 India Allergy Immunotherapy Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in allergy immunotherapy in India are Stallergenes Greer, ALK-Abello, Allergy Therapeutics, and HAL Allergy Group. Stallergenes Greer leads with advanced personalized allergy immunotherapy solutions and holds a dominant share in the food allergy immunotherapy segment due to its FDA- and EMA-approved Palforzia oral immunotherapy for peanut allergy. ALK-Abello is prominent for expanding its sublingual immunotherapy (SLIT) portfolio and securing regulatory approvals, maintaining a strong presence in India's growing market. Allergy Therapeutics focuses on next-generation injectable immunotherapy products and ongoing clinical innovations in India. HAL Allergy Group offers cost-effective regional solutions and contributes effectively alongside these global players.
India’s allergy immunotherapy market is expanding rapidly with a CAGR of about 10%, driven by rising allergy prevalence linked to urbanization and pollution, improved healthcare infrastructure, and increasing public awareness. These companies capitalize on growing diagnostic capabilities and specialty clinics in tier-1 and tier-2 cities. Collaborative partnerships between Indian and global firms facilitate technology transfer, enabling enhanced immunotherapy options tailored to the Indian population's specific allergen profiles. This competitive landscape fosters innovation in subcutaneous and sublingual immunotherapy approaches, supporting India’s emergence as a significant allergy treatment hub in Asia Pacific.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in allergy immunotherapy in India are Stallergenes Greer, ALK-Abello, Allergy Therapeutics, and HAL Allergy Group. Stallergenes Greer leads with advanced personalized allergy immunotherapy solutions and holds a dominant share in the food allergy immunotherapy segment due to its FDA- and EMA-approved Palforzia oral immunotherapy for peanut allergy. ALK-Abello is prominent for expanding its sublingual immunotherapy (SLIT) portfolio and securing regulatory approvals, maintaining a strong presence in India's growing market. Allergy Therapeutics focuses on next-generation injectable immunotherapy products and ongoing clinical innovations in India. HAL Allergy Group offers cost-effective regional solutions and contributes effectively alongside these global players.
India’s allergy immunotherapy market is expanding rapidly with a CAGR of about 10%, driven by rising allergy prevalence linked to urbanization and pollution, improved healthcare infrastructure, and increasing public awareness. These companies capitalize on growing diagnostic capabilities and specialty clinics in tier-1 and tier-2 cities. Collaborative partnerships between Indian and global firms facilitate technology transfer, enabling enhanced immunotherapy options tailored to the Indian population's specific allergen profiles. This competitive landscape fosters innovation in subcutaneous and sublingual immunotherapy approaches, supporting India’s emergence as a significant allergy treatment hub in Asia Pacific.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
